E.P. Svishchenko, L.V. Bezrodnaya Ramipril in the treatment and prevention of cardiovascular diseases

The results of randomized controlled trials and meta-analysis studying the efficiency of ramipril in patients with hypertension, left ventricular hypertrophy, ischemic heart disease, heart failure, diabetic and nondiabetic nephropathy are reviewed. Ramipril has a broad evidence base in relation to positive influence on all stages of cardiovascular continuum and improvement of prognosis. It was studied at wide spectrum of patients, including persons not only with cardiovascular pathology but also with diabetes mellitus and kidney pathology. In a great deal due to research with ramipril the sphere of indications for angiotensin-converting enzyme inhibitors included broader patient categories.

Full article